fondazione per la ricerca farmacologica
gianni benzi onlus
Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus is a Scientific Research Organisation, registered as a private, not-for-profit Foundation in 2007, with the aim to promote research in biological, medical and pharmaceutical areas in support of the development of innovative and safe medicines in Europe.
Discover more about us through this video.
HIGHLIGHTS
Delve into some of the most important activities now running at Fondazione Gianni Benzi
THE ROLE OF YOUNG PATIENTS IN PAEDIATRIC RESEARCH: HIGHLIGHTS FROM THE INVENTS TRAINING COURSE
On 2 and 3 November 2024, the first face-to-face meeting of the INVENTS Paediatric Patient Expert Group (PEG) titled “Innovative methodologies based on in silico models and the secondary use of health data” was held in Bari. Under the European INVENTS project, TEDDY...
FONDAZIONE GIANNI BENZI AT THE ERDERA KICK-OFF MEETING IN PARIS
On 28 and 29 October 2024, Fondazione Gianni Benzi’s President Fedele Bonifazi and Viviana Giannuzzi, Head of Research and Innovation Department, participated in the kick-off meeting of the ERDERA project. This event marked the beginning of a new era in rare disease...
Keep updated on all the initiatives and events of the Gianni Benzi Onlus Foundation dedicated to the comparison of research and training topics.
ICH E11A GUIDELINE ON PAEDIATRIC EXTRAPOLATION STEP 5
The ICH E11A Guideline on paediatric extrapolation reached Step 5 on 21 August 2024, following the public consultation of its draft version in 2022. The primary aim of this guideline is to promote the international harmonisation of paediatric extrapolation to support...
Adoption of the 10th revision of the Declaration of Helsinki
On 19 October 2024 the World Medical Association (WMA) adopted the 10th revision of the Declaration of Helsinki on Ethical Principles for Medical Research Involving Human Participants. This is likely the most significant revision of the Declaration since 2000, as it...
NEW EMA REFLECTION PAPER ON AI IN MEDICINAL PRODUCTS LIFECYCLE NOW AVAILABLE
The European Medicines Agency (EMA) has officially released its final "Reflection paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle" following a public consultation period. This paper explores the potential applications and regulatory...
Nobel Prize for medicine: are miRNAs the key to unlocking the cure for sickle cell anaemia?
This year's Nobel Prize in Medicine has been awarded to two American researchers: Dr. Victor Ambros and Dr. Gary Ruvkun, who discovered microRNAs (miRNAs), a new class of small RNA molecules that play a crucial role in gene regulation. Ambros and Ruvkun's discovery...